
BerGenBio ASA
OSE:BGBIO.OL
0.152 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||
Current Assets: | |||||||||||
Cash & Cash Equivalents
| 140.155 | 155.969 | 150.071 | 435.89 | 720.625 | 252.725 | 359.615 | 369.632 | 161.21 | 73.394 | 126.357 |
Short Term Investments
| 0 | 0.452 | 0 | 0 | 0 | 0 | 0.021 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 140.155 | 156.421 | 150.071 | 435.89 | 720.625 | 252.725 | 359.615 | 369.632 | 161.21 | 73.394 | 126.357 |
Net Receivables
| 0.679 | 0 | 0.68 | 1.45 | 0 | 2.245 | 1.714 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 2.537 | 1.457 | 1.742 | 1.232 | 1.286 | 1.155 | 0.834 | 0.772 | 0 |
Other Current Assets
| 13.709 | 17.483 | 15.86 | 12.399 | 14.228 | 15.818 | 17.832 | 13.43 | 12.301 | 8.038 | 9.125 |
Total Current Assets
| 154.543 | 173.904 | 166.663 | 449.045 | 735.869 | 269.404 | 378.245 | 383.78 | 174.126 | 82.031 | 135.482 |
Non-Current Assets: | |||||||||||
Property, Plant & Equipment, Net
| 1.254 | 0.431 | 0.043 | 1.191 | 2.331 | 0.974 | 0.581 | 0.557 | 0.41 | 0.362 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0.001 | 0 | 0 | 0 | 0 | -0.001 | 0.41 |
Total Non-Current Assets
| 1.254 | 0.431 | 0.043 | 1.191 | 2.332 | 0.974 | 0.581 | 0.557 | 0.41 | 0.361 | 0.41 |
Total Assets
| 155.796 | 174.335 | 166.706 | 450.236 | 738.2 | 270.378 | 378.826 | 384.336 | 174.536 | 82.392 | 121.605 |
Liabilities & Equity: | |||||||||||
Current Liabilities: | |||||||||||
Account Payables
| 12.924 | 18.605 | 29.634 | 26.726 | 22.55 | 26.746 | 23.939 | 21.575 | 10.703 | 5.269 | 4.403 |
Short Term Debt
| 0 | 0.418 | 0 | 0.681 | 0.65 | 1.17 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 35.817 | 41.652 | 22.639 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 19.353 | 27.836 | 48.299 | 1.644 | 1.752 | 0.069 | 17.607 | 12.411 | 10.563 | 6.796 | 5.55 |
Total Current Liabilities
| 32.277 | 46.859 | 77.933 | 64.868 | 66.604 | 50.624 | 41.546 | 33.986 | 21.266 | 12.065 | 9.953 |
Non-Current Liabilities: | |||||||||||
Long Term Debt
| 0.818 | 0 | 0.55 | 0.942 | 2.734 | 0 | 0 | 20.34 | 18.026 | 1.119 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | -0.275 | -0.001 | -1.367 | 0 | 0 | -20.34 | -18.026 | 4.461 | 4.464 |
Total Non-Current Liabilities
| 0.818 | 0 | 0.275 | 0.941 | 1.367 | 0 | 0 | 20.34 | 18.026 | 5.58 | 4.464 |
Total Liabilities
| 33.095 | 46.859 | 78.208 | 65.809 | 67.971 | 50.624 | 41.546 | 33.986 | 21.266 | 17.645 | -5.489 |
Equity: | |||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 39.087 | 268.869 | 8.866 | 8.846 | 8.726 | 6.108 | 5.471 | 4.992 | 3.369 | 2.479 | 2.415 |
Retained Earnings
| 22.019 | -189.234 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | 0 | -1.121 | -0.933 | -0.74 | -0.533 | -0.74 |
Other Total Stockholders Equity
| 61.595 | 47.841 | 35.78 | 375.581 | 628.231 | 187.786 | 309.791 | 345.358 | 149.901 | 62.268 | 112.442 |
Total Shareholders Equity
| 122.701 | 127.476 | 88.498 | 384.427 | 670.229 | 219.754 | 337.28 | 350.35 | 153.27 | 64.747 | 121.605 |
Total Equity
| 122.701 | 127.476 | 88.498 | 384.427 | 670.229 | 219.754 | 337.28 | 350.35 | 153.27 | 64.747 | 121.605 |
Total Liabilities & Shareholders Equity
| 155.796 | 174.335 | 166.706 | 450.236 | 738.2 | 270.378 | 378.826 | 384.336 | 174.536 | 82.392 | 121.605 |